These findings suggest that, more than peak dyskinesia severity per se, for which we nevertheless observed a significant trend, levodopa‐related aberrant oscillatory properties of the SMA determine the rapidity of dyskinesia development.
← all excerpts
Natural Frequencies of Levodopa-Induced Dyskinesia in Parkinson's Disease.
1
—
—